Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Operating Expenses | 2,077 | 1,337 | 1,140 | 1,262 | 2,558 |
| Operating Income | -2,077 | -1,337 | -1,140 | -1,262 | -2,558 |
| Other Income | 45 | -54 | 0 | 4 | 11 |
| Pre-tax Income | -2,032 | -1,391 | -1,140 | -1,258 | -2,547 |
| Net Income Continuous | -2,032 | -1,391 | -1,140 | -1,258 | -2,547 |
| Net Income | $-2,032 | $-1,391 | $-1,140 | $-1,258 | $-2,547 |
| EPS Basic Total Ops | -0.70 | -0.70 | -0.70 | -0.40 | -1.40 |
| EPS Basic Continuous Ops | -0.94 | -0.66 | -0.55 | -0.62 | -1.27 |
| EPS Diluted Total Ops | -0.70 | -0.70 | -0.70 | -0.40 | -1.40 |
| EPS Diluted Continuous Ops | -0.94 | -0.66 | -0.55 | -0.62 | -1.27 |
| EBITDA(a) | $-2,022 | $-1,282 | $-1,086 | $-892 | $-2,505 |